ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "inflammatory arthritis"

  • Abstract Number: 0045 • ACR Convergence 2021

    Endothelial Cells from Patients with DMARD Naïve, Active Inflammatory Arthritis Demonstrate Pro-inflammatory Sensitisation That Is Reversed by Therapy Initiation

    Robert Maughan1, Marie Lang1, Anton Olsson1, Andrew Porter1, Antonia Greeves2, Taryn Youngstein3, Charis Pericleous1 and Justin Mason1, 1Imperial College London, London, United Kingdom, 2Hammersmith Hospital, London, United Kingdom, 3Hammersmith Hospital & Imperial College London, London, United Kingdom

    Background/Purpose: Inflammatory arthritides (IA) including rheumatoid arthritis are associated with increased cardiovascular disease (CVD) mortality. Although inflammation-driven endothelial dysfunction is considered a major factor, the…
  • Abstract Number: 0577 • ACR Convergence 2021

    Comorbidity Burden as Scored Using the Rheumatic Disease Comorbidity Index (RDCI) Is Associated with Varying Treatment Patterns in Patients with Inflammatory Arthritis – a Study Using the EHR-Derived Rheumatic and Arthritis Disease Information Registry (RADIR)

    Diviya Rajesh, Deanna Jannat-Khah, Huong Do, Jonah Levine, Medha Barbhaiya, Lisa Mandl and Vivian Bykerk, Hospital for Special Surgery, New York, NY

    Background/Purpose: Higher comorbidity burden (CB) has been associated with treatment choices in RA, but not assessed in populations including multiple forms of inflammatory arthritis (IA)…
  • Abstract Number: 0786 • ACR Convergence 2021

    Diagnostic Utility of FibroScan in Screening for Liver Injury in Patients with Inflammatory Arthritis on Treatment with Methotrexate (MTX)

    Saman Darabian1, john Wade2, Stefanie Wade3, Jason Kur2 and Maziar Badii2, 1University of British Columbia, North Vancouver, BC, Canada, 2University of British Columbia, Vancouver, BC, Canada, 3Beth Israel Deaconess Medical Center, Boston, MA

    Background/Purpose: Methotrexate (MTX) is often the primary medication to treat various rheumatic diseases, including rheumatoid arthritis, psoriasic arthritis and many other inflammatory diseases. MTX is…
  • Abstract Number: 1131 • ACR Convergence 2021

    Interleukin 6 Concentration in Synovial Fluid and Its Clinical Significance

    Ivars Veckalns and Anna Mihailova, Riga Stradins University, Riga, Latvia

    Background/Purpose: Inflammatory arthritis (IA) treated with disease modifying antirheumatic drugs lead to secondary osteoarthritis (OA) due to inflammation, aging, and other factors. Inflammatory arthritis can…
  • Abstract Number: 1510 • ACR Convergence 2021

    Joint CD8+ Tissue Resident Memory Cell Activation Produces Local Inflammatory Arthritis

    Sahar Lotfi-Emran and David Masopust, University of Minnesota, Minneapolis, MN

    Background/Purpose: Following infection, resident memory CD8+ T cells (TRM) populate tissues as long lived sentinel cells. Their aberrant activation can trigger relapsing inflammation in autoimmune…
  • Abstract Number: 1842 • 2019 ACR/ARP Annual Meeting

    Patients and Relatives Coping with Inflammatory Arthritis: Impact of Communication, Social Support and Relatives Burden on Patients Perceived Health

    Morgane Brignon 1, Catherine Beauvais 2, Martine Beranger 3, Jean-David Cohen 4, Isabelle Griffoul 5, Janine Sophie Le Quintrec 6, Didier Poivret 7, Corinne Thevenot 8, Sonia Trope 9 and Anne-Christine Rat10, 1Université de Lorraine, EA 4360 APEMAC, Nancy, France, 2Saint-Antoine Hospital, Hôpitaux universitaires Est Parisien, AP–HP, Paris, France, 3Orléans Hospital, Orléans, France, 4Montpellier University hospital, Montpellier, France, 5Tours University Hospital, Tours, France, 6Cochin University Hospital, Paris, France, 7Metz Hospital, Metz, France, 8Laon Hospital, Laon, France, 9Andar, Montpellier, France, 10CHU Caen, rheumatology department, Caen Normandie University, Université de Lorraine, EA 4360 APEMAC, Caen, France

    Background/Purpose: Relatives’ and patients’ adjustment to a chronic disease is complex, and there is room for improvement in the support provided to the dyad. So…
  • Abstract Number: 1901 • 2019 ACR/ARP Annual Meeting

    Serious Infections in Offspring Exposed in Utero to Non-TNFi Biologics and Tofacitinib

    Evelyne Vinet1, Yvan St-Pierre 1, Cristiano S. Moura 1, Jeffrey Curtis 2 and Sasha Bernatsky 3, 1McGill University Health Centre, Montreal, QC, Canada, 2University of Alabama at Birmingham, Birmingham, AL, 3Research Institute of the McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: During pregnancy, maternal circulating immunoglobulins G (IgG) are actively transported across the placenta through their Fc portion. Thus, TNFi and other biologics harbouring an Fc…
  • Abstract Number: 2264 • 2019 ACR/ARP Annual Meeting

    Prescribing Exercise: Facilitators and Barriers to the Successful Implementation of Physical Activity Guidelines in Inflammatory Arthritis

    Lauren Freid1, Alexis Ogdie 2 and Joshua Baker 3, 1Hospital of the University of Pennsylvania, Philadelphia, PA, 2Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 3University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Physical Activity (PA) is beneficial for people with inflammatory arthritis (IA).  In 2018, EULAR published the first recommendations for guiding PA in patients with…
  • Abstract Number: 2273 • 2019 ACR/ARP Annual Meeting

    Risk of Serious Infections in Offspring According to TNFi Subtypes

    Evelyne Vinet1, Yvan St-Pierre 1, Cristiano S. Moura 1, Jeffrey Curtis 2 and Sasha Bernatsky 3, 1McGill University Health Centre, Montreal, QC, Canada, 2University of Alabama at Birmingham, Birmingham, AL, 3Research Institute of the McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: TNFi subtypes have differential placental transfer, with some reaching higher fetal than maternal blood levels. Thus, certain TNFi subtypes could cause immunosuppression in the offspring.…
  • Abstract Number: 2369 • 2019 ACR/ARP Annual Meeting

    Treatment Patterns with Disease Modifying Anti-rheumatic Drugs in United States Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis

    Rebecca Overbury1, Shaobo Pei 2, Gopi Penmetsa 3, Brian Sauer 2, Vikas Patil 2, Jodi Walker 4, Jerry Clewell 4, Kevin Douglas 4, Daniel Clegg 5, Grant Cannon 6, Ahmad Halwani 7 and Jessica Walsh 8, 1Assisstant Professor, University of Utah, Salt Lake City, UT, 2Division of Epidemiology, Department of Internal Medicine, Salt Lake City Veteran Affairs and University of Utah Medical Centers, Salt Lake City, UT, 3Gopi K. Penmetsa, MD, Division of Rheumatology, Department of Internal Medicine, Salt Lake City Veteran Affairs and University of Utah Medical Centers, Salt Lake City, UT, 4AbbVie Inc., Salt Lake City, UT, 5University of Utah, Salt Lake City, UT, 6Salt Lake City VA Medical Center and Univeristy of Utah, Salt Lake City, UT, 7Division of Hematology, Department of Internal Medicine, Salt Lake City Veteran Affairs and University of Utah Medical Centers, Salt Lake City, UT, 8Division of Rheumatology, University of Utah, Salt Lake City, UT

    Background/Purpose: Delays in treatment for inflammatory arthritis (IA) are associated with unfavorable outcomes, including impaired quality of life, irreversible joint damage, and disability. Our objective…
  • Abstract Number: 2480 • 2019 ACR/ARP Annual Meeting

    Opioid Use Surrounding Diagnosis of Inflammatory Arthritis

    Anna Sheahan1, Victor Sloan 1, Jeffrey Stark 2 and Robert Suruki 1, 1UCB Pharma, Raleigh, NC, 2UCB Pharma, Smyrna, GA

    Background/Purpose: Although treatment of inflammatory arthritis (IA) has improved, opioid use among patients remains common. A study from Finland showed increases in opioid use leading…
  • Abstract Number: 2857 • 2019 ACR/ARP Annual Meeting

    Decision Tree Analysis to Identify Inflammatory Arthritis Patient Subgroups with Different Levels of Treatment Persistence with First-Line Subcutaneous TNF-alpha Inhibitors

    Emma Hernlund 1, Johan Klint 1, Axel Svedbom 1, Johan Dalén 1, Christopher Black 2 and Amy Puenpatom2, 1ICON plc, Stockholm, Sweden, Stockholm, Sweden, 2Merck & Co., Inc., Kenilworth, NJ, United States, Kenilworth, NJ

    Background/Purpose: The advent of biologic medications, such as subcutaneous TNF-alpha inhibitors (SC-TNFi), has transformed the management of inflammatory arthritis (IA) during the last decades. However,…
  • Abstract Number: 483 • 2019 ACR/ARP Annual Meeting

    Can a Single Question on Functional Impairments Facilitate the Diagnosis of Early Inflammatory Arthritis? A Cross-Sectional Derivation and Validation Study in Two Early Arthritis Recognition Clinics

    Bastiaan van Dijk1, Hanna van Steenbergen 1, Ellis Niemantsverdriet 1 and Annette van der Helm-van Mil 2, 1Leiden University Medical Center, Leiden, Netherlands, 2LUMC, Leiden, Zuid-Holland, Netherlands

    Background/Purpose: Early treatment initiation in RA is associated with improved outcomes but requires early identification of synovitis. Joint swelling in early inflammatory arthritis (IA) may…
  • Abstract Number: 997 • 2019 ACR/ARP Annual Meeting

    Stromal Cell-derived DCSTAMP Coordinates Cell Migration and Osteoclast Activation in TNF-driven Murine Arthritis

    Maria de la luz Garcia-Hernandez1, Javier Rangel-Moreno 2, Benjamin Korman 2, Ananta Paine 1, Nelson Huertas 3 and Christopher T. Ritchlin 3, 1Division of Allergy, Immunology and Rheumatology, Center for Musculoskeletal Research, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA, Rochester, NY, 2University of Rochester Medical center, Rochester, NY, 3University of Rochester, Rochester, NY

    Background/Purpose: DC-STAMP is a transmembrane protein involved in the fusion of mononuclear osteoclasts and essential for the formation of fully functional multinucleated osteoclasts (OCs). Recently…
  • Abstract Number: 1360 • 2019 ACR/ARP Annual Meeting

    Ultrasound Guided Synovial Biopsies Safely Aid in the Assessment of Inflammatory Arthritis

    Khin Lim1, Ami Ben-artzi 1, Lindsy Forbess 1, Swamy Venuturupalli 2, John Jalas 3 and Mariko Ishimori 1, 1Cedars-Sinai Medical Center, Los Angeles, CA, 2Cedars Sinai Medical Center, Los Angeles, CA, 3Saint John Health Center, Los Angeles, CA

    Background/Purpose: Synovial biopsies have an important role in the diagnostic evaluation of patients with undifferentiated inflammatory arthritis (UIA) whose clinical examination and blood and synovial…
  • 1
  • 2
  • 3
  • …
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology